Japanese researchers have developed artificial blood, potentially revolutionizing emergency medicine and addressing global ...

A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.

EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

The emergency room (ER) at a veterinary hospital is a place of urgency, heartbreak, hope, and, sometimes , miracles.  This ...

Mattel introduces a new Barbie doll representing Type 1 diabetes, complete with an insulin pump and glucose monitor, marking ...

We're delighted to announce $6.5 million in philanthropic investments from the Colonial Foundation and philanthropist, David Russell, to supercharge ...

NHS GP and ITV's Dr Amir Khan has shared a reason you may be getting colds and infections more regularly than normal, and ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 million school- and workdays ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...

Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

Hereditary-patterned baldness, also called androgenic alopecia, affects people across genders, ages, and ethnic backgrounds. By age 50, roughly half of Asian men and up to 80 percent of White men face ...